1.
Renner C, Zinzani PL, Gressin R, Klingbiel D, Dietrich P-Y, Hitz F, Bargetzi M, Mingrone W, Martinelli G, Trojan A, Bouabdallah K, Lohri A, Gyan E, Biaggi C, Cogliatti S, Bertoni F, Ghielmini M, Brauchli P, Ketterer N. A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma. Haematologica [Internet]. 2012Jul.13 [cited 2026Nov.16];97(7):1085-91. Available from: https://haematologica.org/article/view/6354